I know this creates a lot of distraction, anxiety and confusion. You have many questions. We will have time to answer them all. This week, we will conduct live virtual meetings to answer your questions. Within the next couple of days, I will have a Town Hall meeting to introduce you to Analog Device’s CEO, Vince Roche. You will see that our companies have a lot of similarities, including the highest regard for quality engineering, innovation, and people. We will also discuss why we believe this combination is a good long-term decision within our industry.
This approval process will take many, many months. During that time, the two companies remain independent. So, we must not get distracted from running our business. We need to execute on our AOP and keep moving forward. Until regulatory approvals are obtained, the stockholders of both parties approve the transaction and the deal has closed, it is our job to run the business of Maxim. We remain responsible to keep the business, our customers, and our employees strong, growing, and well served.
This has been a wonderful journey, my friends. I have been honored and humbled to call each of you my colleague and my friend. But we are not turning out the lights. We are not stopping here. Our job now is to look around the corner and write the next chapter of Maxim. We will do it together. Let’s write one deserving of the Maxim name, and one which would make all of those who built Maxim proud.
You have my support as we go forward. I know I can count on yours.
Tunç
Forward Looking Statements
This communication relates to a proposed business combination transaction between Analog Devices, Inc. (“ADI”) and Maxim Integrated Products, Inc. (“Maxim”). This communication contains “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements address a variety of subjects, including, for example, projections as to the anticipated benefits of the proposed transaction, the anticipated impact of the proposed transaction on the combined organization’s business and future financial and operating results, the expected amount and timing of synergies from the proposed transaction, and the anticipated closing date for the proposed transaction. Statements that are not historical facts, including statements about ADI’s and Maxim’s beliefs, plans and expectations, are forward-looking statements. Such statements are based on ADI’s and Maxim’s current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking statements often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “would,” “target” and similar expressions, as well as variations or negatives of these words. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: the uncertainty as to the extent of the duration, scope and impacts of the COVID-19 pandemic; political and economic uncertainty, including any faltering in global economic conditions or the stability of credit and financial markets, erosion of consumer confidence and declines in customer spending; unavailability of raw materials, services, supplies or manufacturing capacity; changes in geographic scope or product or customer mix; changes in export classifications, import and export regulations or duties and tariffs; changes in ADI’s or Maxim’s estimates of their expected tax rate based on current tax law; ADI’s ability to successfully integrate Maxim’s businesses and technologies; the risk that the expected benefits and synergies of the proposed transaction and growth prospects of the combined company may not be fully achieved in a timely manner, or at all; adverse results in litigation matters, including the potential for litigation related to the proposed transaction; the risk that ADI or Maxim will be unable to retain and hire key personnel; the risk associated with ADI’s and Maxim’s ability to obtain the approvals of their respective shareholders required to consummate the proposed transaction and the timing of the closing of the proposed transaction, including the risk that the conditions to the transaction are not satisfied on a timely basis or at all or the failure of the transaction to close for any other reason or to close on the anticipated terms, including the anticipated tax treatment; the risk that any regulatory approval, consent or authorization that may be required for the proposed transaction is not obtained or is obtained subject to conditions that are not